Principles for modulation of the nuclear receptor superfamily

@article{Gronemeyer2004PrinciplesFM,
  title={Principles for modulation of the nuclear receptor superfamily},
  author={Hinrich Gronemeyer and Jan-{\AA}ke Gustafsson and Vincent Laudet},
  journal={Nature Reviews Drug Discovery},
  year={2004},
  volume={3},
  pages={950-964}
}
Nuclear receptors are major targets for drug discovery and have key roles in development and homeostasis, as well as in many diseases such as obesity, diabetes and cancer. This review provides a general overview of the mechanism of action of nuclear receptors and explores the various factors that are instrumental in modulating their pharmacology. In most cases, the response of a given receptor to a particular ligand in a specific tissue will be dictated by the set of proteins with which the… Expand
Nuclear receptors and their relevance to diseases related to lipid metabolism.
TLDR
Targeting of classical nuclear receptor family members with better characterized endocrinology and roles in lipid metabolism, such as the thyroid and steroid hormone receptors, could become of renewed pharmacological interest, as these targets provide well-characterized alternatives to the more recently discovered nuclear receptors. Expand
Overview of Nomenclature of Nuclear Receptors
TLDR
The characterization of nuclear receptors and their associated proteins and the ligands that interact with them will remain a challenge to pharmacologists. Expand
What are nuclear receptor ligands?
  • F. Sladek
  • Biology, Medicine
  • Molecular and Cellular Endocrinology
  • 2011
TLDR
The purpose of this review is to provide a broad perspective on NR ligands and address the issue of exactly what constitutes a NR ligand from historical, biological and evolutionary perspectives. Expand
Inverse agonists and antagonists of retinoid receptors.
TLDR
The current structural and mechanistic insight into the functionalities of subsets of retinoid and rexinoid ligands that act generically as antagonists but follow different mechanistic principles, resulting in "classical" or neutral antagonism, or inverse agonism is reviewed. Expand
Therapeutic potential of nuclear receptors
TLDR
This review provides an overview on the molecular classification and disease relevance of NRs, as well as on recent advances in pharmacologic (pre-clinical targeting approaches and patent applications, using various databases and websites. Expand
Nuclear Receptors as Drug Targets: A Historical Perspective of Modern Drug Discovery
TLDR
A number of nuclear receptors identified in recent years do not have any known ligands and these so-called orphan receptors have attracted considerable interest since they could lead to the discovery of new endocrine regulatory systems. Expand
Noncanonical mechanisms to regulate nuclear receptor signaling.
TLDR
This article reviews each of these promising emerging strategies for NR drug development and highlights some of most significant successes achieved in using them. Expand
Targeting liver X receptors in cancer therapeutics
TLDR
This Review summarizes the discovery and characterization of LXRs and their ligands, their effects and mechanisms in preclinical cancer models, and the future directions of basic and translational LXR research in cancer therapeutics. Expand
A structural perspective on nuclear receptors as targets of environmental compounds
TLDR
A structural and mechanistic view of endocrine disrupting action using estrogen receptors α and β, (ERα/β), peroxisome proliferator activated receptor γ (PPARγ), and their respective environmental ligands as representative examples are provided. Expand
Retinoid receptors and therapeutic applications of RAR/RXR modulators.
TLDR
Strategies in the design of selective RXR and RAR modulators are described and the structural mechanisms by which the diverse pharmacological classes of compounds modulate receptor functions are reviewed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 157 REFERENCES
Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications.
TLDR
A comprehensive mechanistic view of agonist and antagonist action will be presented and the novel class of partial agonists-antagonists will be described and the multiple challenges and novel perspectives for nuclear-receptor-based drug design will be discussed. Expand
Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.
TLDR
A model for a complex with the RARgamma-specific agonist CD666 is proposed that shows the possible applications for structure-based drug design of RAR isotype-selective retinoids. Expand
Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand.
TLDR
The purpose of this review is to summarize knowledge of the nature of ERR activities and progresses in identifying synthetic ERR modulators. Expand
The coregulator exchange in transcriptional functions of nuclear receptors.
TLDR
Based on their importance in biology and medicine, as well as the relatively simple mechanism of regulation, NR represent one of the most intensively studied and best-understood classes of transcription factors at the molecular level. Expand
Orphan nuclear receptors--new ligands and new possibilities.
TLDR
Advances made on four new orphan receptor-mediated signaling pathways [BXR (benzoate X receptor), CARb (constitutive androstane receptor), PxR (pregnane X receptors), and SXR (steroid and Xenobiotic receptor)] are highlighted with brief updates on recent progress for FXR, PPARg, and LXRa. Expand
Retinoic Acid Is a High Affinity Selective Ligand for the Peroxisome Proliferator-activated Receptor β/δ*
TLDR
It is shown that RA is a high affinity ligand for another nuclear receptor, namely the orphan receptor peroxisome proliferator-activated receptor (PPAR) β/δ, which indicates that transcriptional signaling by RA is exerted by a dual pathway, providing a rationale for understanding divergent cellular responses to this hormone. Expand
The evolution of the nuclear receptor superfamily.
TLDR
The study of the evolution of nuclear receptors will be very important not only for understanding their functions in vivo but also for obtaining insights into the evolutionof animal genomes as a whole. Expand
Ligand-independent coregulator recruitment by the triply activatable OR1/retinoid X receptor-alpha nuclear receptor heterodimer.
TLDR
It is shown that in vitro the steroid receptor coactivator SRC-1 can be recruited by RXRalpha upon addition of its ligand, and to OR1Upon addition of 22(R)-OH-cholesterol, demonstrating that the latter can act as a direct ligand to Or1. Expand
Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs).
TLDR
It is suggested that selective PPARgamma modulators (SPARMs), designed to have desired effects on specific genes and target tissues without undesirable effects on others, will be clinically important in the future for chemoprevention and chemotherapy of cancer. Expand
A canonical structure for the ligand-binding domain of nuclear receptors
TLDR
Mutant studies support a general mechanism for ligand-induced activation deduced from the comparison of the transcriptionally active RARγ holo- and inactive RXRα apo-LBD structures. Expand
...
1
2
3
4
5
...